


Akhu Therapeutics Revenue
Biotechnology Research • Irvine, California, United States • 1-10 Employees
Akhu Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Akhu Therapeutics
Caurnel Morgan
CEO, President
Company overview
| Headquarters | 383 Shadow Oaks, Irvine, California 92618, US |
| Website | |
| NAICS | 541714 |
| SIC | 736 |
| Keywords | Biotechnology, Pharmaceuticals, Peptide Therapeutics |
| Founded | 2015 |
| Employees | 1-10 |
About Akhu Therapeutics
Akhu Therapeutics is developing medicine for anxiety and depression in humans and companion animals to be faster, more effective, and safer than antidepressants and anxiolytics.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Akhu Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Akhu Therapeutics has never raised funding before.
Akhu Therapeutics Tech Stack
Discover the technologies and tools that power Akhu Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web servers
Programming languages
Frequently asked questions
4.8
40,000 users



